117 related articles for article (PubMed ID: 38491523)
1. Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.
Pan Y; Jin X; Xu H; Hong J; Li F; Luo T; Zeng J
Sci Rep; 2024 Jun; 14(1):13113. PubMed ID: 38849442
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma.
Feng R; Li H; Meng T; Fei M; Yang C
Discov Oncol; 2024 May; 15(1):187. PubMed ID: 38797784
[TBL] [Abstract][Full Text] [Related]
3. Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma.
Feng K; Zhou S; Sheng Y; Lu K; Li C; Liu W; Kong H; Liu H; Mu Y; Zhang L; Zhang Q; Wang J
Clin Genitourin Cancer; 2024 Apr; 22(4):102095. PubMed ID: 38833825
[TBL] [Abstract][Full Text] [Related]
4. Construction of a novel disulfidptosis-related lncRNAs signature for prognosis prediction and anti-tumor immunity in laryngeal squamous cell carcinoma.
Zhang M; Sun Q; Han Z; Qin X; Gao T; Xu Y; Han S; Zhang Y; Liang Q; Guo Z; Liu J
Heliyon; 2024 May; 10(10):e30877. PubMed ID: 38774325
[TBL] [Abstract][Full Text] [Related]
5. Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma.
Yao H; Liu P; Yao L; Li X
Cancer Cell Int; 2024 May; 24(1):183. PubMed ID: 38802854
[TBL] [Abstract][Full Text] [Related]
6. Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.
Chen G; Zhang G; Zhu Y; Wu A; Fang J; Yin Z; Chen H; Cao K
Cancer Cell Int; 2024 Jun; 24(1):194. PubMed ID: 38831301
[TBL] [Abstract][Full Text] [Related]
7. Integrating disulfidptosis-related long noncoding RNAs in colorectal cancer prognosis: A path to precision medicine.
Zhang SY
World J Clin Oncol; 2024 May; 15(5):664-666. PubMed ID: 38835842
[TBL] [Abstract][Full Text] [Related]
8. A novel prognostic model between ferroptosis, cuproptosis, and disulfidptosis in predicting prognosis lung adenocarcinoma.
Sun J; Guan C; Wang X; Zhu Z
Asian J Surg; 2024 Jun; ():. PubMed ID: 38849245
[No Abstract] [Full Text] [Related]
9. RNA sequencing-based approaches to identifying disulfidptosis-related diagnostic clusters and immune landscapes in osteoporosis.
Zhang P; Li B; Chen H; Ge Z; Shang Q; Liang D; Yu X; Ren H; Jiang X; Cui J
Aging (Albany NY); 2024 May; 16(9):8198-8216. PubMed ID: 38738994
[TBL] [Abstract][Full Text] [Related]
10. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.
Zhou S; Liu J; Wan A; Zhang Y; Qi X
J Hematol Oncol; 2024 Apr; 17(1):22. PubMed ID: 38654314
[TBL] [Abstract][Full Text] [Related]
12. Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology.
Chen R; Wu J; Che Y; Jiao Y; Sun H; Zhao Y; Chen P; Meng L; Zhao T
Eur J Med Res; 2024 Mar; 29(1):176. PubMed ID: 38491523
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.
Bai Z; Lu J; Chen A; Zheng X; Wu M; Tan Z; Xie J
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551318
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
